Patent Assignment
Reel/Frame 050922/0607
Assignment of Assignor's Interest
Recorded: 2019-11-05
Pages: 9
Assignor
TABUTEAU, HERRIOT
Executed: 2019-06-20
Assignee
AXSOME THERAPEUTICS, INC.
200 BROADWAY, 3RD FLOOR, NEW YORK, NEW YORK, 10038
Covered Properties
(4)
Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion
PCT:
PCT/US2019/052210 ↗
Dosage Forms Comprising Active Pharmaceutical Ingredients
PCT:
PCT/US2019/053167 ↗
Pharmaceutical Compositions Comprising Meloxicam
Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Intellectual Property Security Agreement
Sep 25, 2020
From: AXSOME THERAPEUTICS, INC.
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 053941/0491 →
Security Interest
May 9, 2025
From: AXSOME THERAPEUTICS, INC.; AXSOME MALTA LTD.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 071247/0836 →
Release of Security Interest
May 22, 2025
From: HERCULES CAPITAL, INC.
To: AXSOME THERAPEUTICS, INC.
Reel/Frame 071337/0004 →